Reduction of SIRT1 levels was also demonstrated in parietal cortex in patients with Alzheimer’s disease, which was associated with the accumulation of Aβ and Tau [97], whereas activation of SIRT1 can suppress α-synuclein aggregation [98]. This evidence concerns the gene MAPT and Alzheimer disease.